The global narcolepsy market accounted to US$ 2,026.8 Mn in 2018 and is expected to grow at a CAGR of 9.5% during the forecast period 2019 – 2027, to account to US$ 4,537.9 Mn by 2027.
Key factors driving the market are rising prevalence of sleep related disorders, emerging local pharmaceutical & bio pharmaceutical companies, and increasing awareness regarding neurological disorders. However, factors such as side effects and risks associated with narcolepsy medications and delayed diagnosis or misdiagnosis of narcolepsy are likely to restrain the market growth to a certain extent.
The prominent players operating in narcolepsy market are Bioprojet, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Graymark Healthcare, Arena Pharmaceuticals, Shire (Acquired by Takeda), Ligand Pharmaceuticals, Novartis AG, Mylan N.V., and Shionogi.
An exclusive Narcolepsy market research report created through broad primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Narcolepsy market with Segments. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Narcolepsy market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Rising prevalence of sleep related neurological disorders is driving the market for narcolepsy over the forecast period.
Key Elements that the report acknowledges:
- Market size and growth rate during forecast period.
- Key factors driving the Narcolepsy Market
- Key market trends cracking up the growth of the Narcolepsy Market
- Challenges to market growth.
- Key vendors of Narcolepsy Market
- Detailed SWOT analysis.
- Opportunities and threats faces by the existing vendors in global market
- Trending factors influencing the market in the geographical regions.
- Strategic initiatives focusing the leading vendors.
- PEST analysis of the market in the five major regions.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Narcolepsy market based on product and application. It also provides market size and forecast till 2027 for overall Narcolepsy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.
Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Narcolepsy Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Narcolepsy Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.